Brendan Luu - 01 Dec 2024 Form 4 Insider Report for ENANTA PHARMACEUTICALS INC (ENTA)

Role
Chief Business Officer
Signature
/s/ Matthew Kowalsky as attorney-in-fact
Issuer symbol
ENTA
Transactions as of
01 Dec 2024
Net transactions value
-$6,476
Form type
4
Filing time
03 Dec 2024, 18:41:13 UTC
Previous filing
27 Nov 2024
Next filing
10 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENTA Common Stock Tax liability $6,476 -753 -1.9% $8.60 38,330 01 Dec 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on November 19, 2021.